Dr. Keasling is a Professor of Chemical engineering and Bioengineering at the University of California-Berkeley, Associate Laboratory Director at Lawrence Berkeley National Laboratory, Chief Executive Officer of the Joint BioEnergy Institute, and Director of the Synthetic Biology Engineering Research Center. He joined the UC-Berkeley faculty in 1992 and is considered one of the foremost authorities in synthetic biology, especially in the field of metabolic engineering. Dr. Keasling is also a co-founder of Codon Devices, Amyris, and LS9.

Dr. Katz currently serves as President of the Society for Industrial Microbiology and Biotechnology and Director of Research and Industry Relations for the Synthetic Biology Engineering Research Center. Prior to these roles, he was Vice President of Biological Sciences at Kosan Biosciences and Project Leader & Research Fellow at Abbott Laboratories.

Dr. Bailey is currently consulting with numerous industrial biotechnology companies following a successful career spanning 34 years. During this career, he participated in, or managed the development, scale-up, and subsequent commercialization of several biochemical processes. He was the CEO of Microbia, Inc. and held senior management positions for several divisions of Monsanto with responsibilities for programs in both fermentation process development and agricultural biotechnology. Dr. Bailey has served as a Scientific Advisor to Allylix, BioAmber, and Bio Architecture Lab.

Dr. Cockrem has 25+ years experience in process development for commercialization of bio-based chemicals, including lactic acid, succinic acid, isoprene, 1,3-propanediol, and 1,4-butanediol with specific expertise in product purification and process modeling. Dr. Cockrem completed his Ph.D. in Chemical Engineering at University of Wisconsin-Madison, after coming to the USA from New Zealand as a Fulbright Scholar. He is an inventor for over 21 issued US patents or patent applications.

Dr. Cooney is professor of chemical and biochemical engineering and faculty director for the Deshpande Center for Technological Innovation at the Massachusetts Institute of Technology. He joined the MIT faculty as an assistant professor in 1970 and became a professor in 1982. Dr. Cooney is an expert in fermentation and downstream processing. He is on the board of directors of Genzyme and CUNO, Inc. and serves as a consultant to a number of biotech and pharmaceutical companies, from startups to global corporations.

Mr. Millis is currently Chief Technology Officer of Nature's Fynd and has over 30 years experience in the commercialization of numerous bio-based chemicals. Most recently, Mr. Milis was Chief Technology Officer of BioAmber Inc. and President and CEO of Draths Corporation. Prior to these roles, he was Technical Director of Industrial Bioproducts at Cargill and Process Development Director at Codexis. Mr. Millis has a B.S. from Cornell University and MS from the University of Pittsburgh in Chemical Engineering.

Dr. del Cardayre is currently active with several leading synthetic biology and specialty chemical companies. Most recently, Dr. del Cardayre Vice President of Life Science Research and Development of Renewable Energy Group and LS9, Inc. Prior to that, Dr. del Cardayre was head of Microbiology at Codexis and Scientist at Maxygen. Dr. del Cardayre received his bachelor's from the University of California, Berkeley and Ph.D. from the University of Wisconsin, Madison in Biochemistry.